US FDA accepts Samsung Bioepis' application for Humira biosimilar
… anti-tumor necrosis factor monoclonal antibody that currently treats Crohn's disease, rheumatoid arthritis, ulcerative colitis, hidradenitis suppurativa, …
Blog - Latest News
You are here: Home / Hidradenitis suppurativa / US FDA accepts Samsung Bioepis' application for Humira biosimilar
Interesting links
Here are some interesting links for you! Enjoy your stay :)Categories
Archive
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
Leave a Reply
Want to join the discussion?Feel free to contribute!